Akèy › Maladi pwostat
Etid klinik pou Maladi pwostat ap rekrite nan Etazini
8 etid pou Maladi pwostat ap rekrite patisipan nan sit atravè Etazini.
Pa eta
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Sep 10, 2026 · NCT05997615A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Jul 9, 2026 · NCT07103018Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
Ap rekriteFaz 1/2
Laj 18 ak plis · Gason · Mizajou May 14, 2026 · NCT05413850Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer
Ap rekriteFaz 1/2
Laj 18 ak plis · Gason · Mizajou Apr 13, 2026 · NCT061908995-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
Ap rekrite
Laj 50 ak plis · Gason · Mizajou Oct 28, 2025 · NCT04288427Exploring the Potential of Robotic Telesurgery in Remote Settings
Ap rekrite
Laj 18 a 90 · Gason · Mizajou Aug 19, 2025 · NCT07130708Evaluation of the Performance of a Novel Prostate Biopsy System Compared With Standard of Care Biopsy Needle on Quantitative and Qualitative Tissue Parameters
Ap rekrite
Laj 18 a 90 · Gason · Mizajou May 7, 2025 · NCT0547012718F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
Ap rekriteFaz 4
Laj 18 ak plis · Gason · Mizajou Nov 27, 2024 · NCT06706921Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.